Cite
[Mutation of EGFR signaling pathway and therapy for metastatic colorectal cancer].
MLA
Nozawa, Keijirou, and Toshiaki Watanabe. “[Mutation of EGFR Signaling Pathway and Therapy for Metastatic Colorectal Cancer].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 37, no. 5, May 2010, pp. 791–94. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=20495308&authtype=sso&custid=ns315887.
APA
Nozawa, K., & Watanabe, T. (2010). [Mutation of EGFR signaling pathway and therapy for metastatic colorectal cancer]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 37(5), 791–794.
Chicago
Nozawa, Keijirou, and Toshiaki Watanabe. 2010. “[Mutation of EGFR Signaling Pathway and Therapy for Metastatic Colorectal Cancer].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 37 (5): 791–94. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=20495308&authtype=sso&custid=ns315887.